Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Andrographis paniculata extract × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Gastrointestinal 1

Conditions

Esophageal Squamous Cell Carcinoma 1

Interventions

Oxaliplatin 1261 Fluorouracil 1170 Capecitabine 969 Gemcitabine 922 Leucovorin 832 Bevacizumab 738 Irinotecan 730 Cisplatin 592 Radiotherapy 504 Cetuximab 422 pembrolizumab 385 Paclitaxel 352 Drug Therapy 317 Nivolumab 298 130-nm albumin-bound paclitaxel 278 Docetaxel 262 Sorafenib 257 S 1 (combination) 250 Folfox protocol 237 Surgical Procedures, Operative 225 Albumin-Bound Paclitaxel 220 lenvatinib 191 durvalumab 191 apatinib 186 tislelizumab 182 sintilimab 178 regorafenib 175 Radiosurgery 174 Magnetic Resonance Spectroscopy 172 Neoadjuvant Therapy 171

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04196075 2021-11-08

AP

Chinese University of Hong Kong

Phase 3 Completed

Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡